|
Model Number BB811 |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/31/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that prior to use of a fusion oxygenator, it was reported that priming fluid leaked from the purge line of the artificial lung.The customer observed that the custom tubing pack circuit used at the same time was dirty.The customer stated that since the issue was observed during priming, all circuits and centrifugal pumps were replaced to complete the procedure and additional time was used in preparation but did not affect the start of surgery.There was no patient involvement, so no adverse effect occurred.Medtronic received additional information that the leak was only at the purge line of oxygenator.No foreign matter has been identified, the material on the custom tubing pack circuit was priming solution.The fusion oxygenator and cardiotomy venous reservoir (cvr) which were used were not part of the custom tubing pack.Medtronic received additional information that the leaking line was coming out of the oxygenator and was connected to the cvr.
|
|
Manufacturer Narrative
|
Product analysis: visual inspection showed evidence of damage/hole in the air purge line.The device appeared to have been primed.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed from the damaged area.The reason for return was confirmed.Conclusion: the complaint was confirmed for the torn and leaking fusion oxygenator purge line.The issue was identified during analysis of the returned device which showed evidence of damage/hole in the air purge line, and pressure integrity testing resulted in a leak from the tear.This type of damage would not be acceptable during manufacturing.Review of this devices¿ device history record found no abnormalities or non-conforming material reports initiated during manufacturing that would cause or contribute to the reported event.This device passed all testing and inspections during manufacturing.The root cause is unknown, but potentially related to damage occurring during shipping or storage.There were no patient/clinical safety issues reported.Trends for issues with this device are reviewed at quarterly quality meetings.Correction section d 4.4 lot number: this field has been updated.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|